Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
American Society for Radiation Oncology to hold annual meeting » 04:55
10/27/21
10/27
04:55
10/27/21
04:55
ARAY

Accuray

$4.31 /

-0.08 (-1.82%)

, NVS

Novartis

$84.84 /

+1.49 (+1.79%)

, AZN

AstraZeneca

$62.29 /

+0.54 (+0.87%)

, BAYRY

Bayer

$14.20 /

+0.04 (+0.28%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.76 /

-0.08 (-2.08%)

, BSX

Boston Scientific

$44.32 /

-0.17 (-0.38%)

, BMY

Bristol-Myers

$58.24 /

+0.47 (+0.81%)

, EKTAY

Elekta

$11.58 /

+0.09 (+0.78%)

, GRTX

Galera Therapeutics

$1.88 /

+0.04 (+2.17%)

, DNA

Ginkgo Bioworks

$14.46 /

+0.19 (+1.33%)

, HTHIY

Hitachi

$118.77 /

-0.71 (-0.59%)

, MRK

Merck

$82.23 /

+0.545 (+0.67%)

, MYGN

Myriad Genetics

$30.66 /

-1.81 (-5.57%)

, NBTX

Nanobiotix

$12.35 /

-0.3 (-2.37%)

, NNOX

Nano-X Imaging

$22.54 /

-0.55 (-2.38%)

, NTRA

Natera

$115.95 /

+0.2 (+0.17%)

, NVCR

Novocure

$113.51 /

-5.91 (-4.95%)

, PHG

Philips

$47.69 /

-0.12 (-0.25%)

, REGN

Regeneron

$592.37 /

+16.45 (+2.86%)

, SNY

Sanofi

$49.98 /

+0.125 (+0.25%)

, SGEN

Seagen

$177.70 /

+2.29 (+1.31%)

, SMMNY

Siemens Healthineers

$34.66 /

-0.07 (-0.20%)

, SYK

Stryker

$273.25 /

+0.08 (+0.03%)

, TDY

Teledyne

$437.11 /

-7.89 (-1.77%)

, VRAY

ViewRay

$6.96 /

-0.05 (-0.71%)

, VREX

Varex Imaging

$26.36 /

-0.7 (-2.59%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

10/26/21 Lake Street
Investors should buy Accuray after 'excellent' ASTRO meeting, says Lake Street
01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$84.84 /

+1.49 (+1.79%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
EKTAY Elekta
$11.58 /

+0.09 (+0.78%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$82.23 /

+0.545 (+0.67%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$115.95 /

+0.2 (+0.17%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$113.51 /

-5.91 (-4.95%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$47.69 /

-0.12 (-0.25%)

10/25/21 Credit Suisse
Philips price target lowered to EUR 42 from EUR 49 at Credit Suisse
10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
REGN Regeneron
$592.37 /

+16.45 (+2.86%)

10/26/21 SVB Leerink
Regeneron price target raised to $798 from $785 at SVB Leerink
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
SGEN Seagen
$177.70 /

+2.29 (+1.31%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$273.25 /

+0.08 (+0.03%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$437.11 /

-7.89 (-1.77%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

VRAY ViewRay
$6.96 /

-0.05 (-0.71%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

NBTX Nanobiotix
$12.35 /

-0.3 (-2.37%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BIOC Biocept
$3.76 /

-0.08 (-2.08%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

ARAY Accuray
$4.31 /

-0.08 (-1.82%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.98 /

+0.125 (+0.25%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

HTHIY Hitachi
$118.77 /

-0.71 (-0.59%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

VREX Varex Imaging
$26.36 /

-0.7 (-2.59%)

SYK Stryker
$273.25 /

+0.08 (+0.03%)

SNY Sanofi
$49.98 /

+0.125 (+0.25%)

SMMNY Siemens Healthineers
$34.66 /

-0.07 (-0.20%)

SGEN Seagen
$177.70 /

+2.29 (+1.31%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

PHG Philips
$47.69 /

-0.12 (-0.25%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NVCR Novocure
$113.51 /

-5.91 (-4.95%)

NTRA Natera
$115.95 /

+0.2 (+0.17%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

MYGN Myriad Genetics
$30.66 /

-1.81 (-5.57%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BAYRY Bayer
$14.20 /

+0.04 (+0.28%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

TDY Teledyne
$437.11 /

-7.89 (-1.77%)

REGN Regeneron
$592.37 /

+16.45 (+2.86%)

NVS Novartis
$84.84 /

+1.49 (+1.79%)

NNOX Nano-X Imaging
$22.54 /

-0.55 (-2.38%)

MRK Merck
$82.23 /

+0.545 (+0.67%)

GRTX Galera Therapeutics
$1.88 /

+0.04 (+2.17%)

DNA Ginkgo Bioworks
$14.46 /

+0.19 (+1.33%)

BSX Boston Scientific
$44.32 /

-0.17 (-0.38%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

AZN AstraZeneca
$62.29 /

+0.54 (+0.87%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 04:55
10/26/21
10/26
04:55
10/26/21
04:55
ARAY

Accuray

$4.39 /

+0.02 (+0.46%)

, NVS

Novartis

$83.37 /

-1.515 (-1.78%)

, AZN

AstraZeneca

$61.75 /

-0.06 (-0.10%)

, BAYRY

Bayer

$14.16 /

+0.025 (+0.18%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.84 /

-0.02 (-0.52%)

, BSX

Boston Scientific

$44.49 /

-0.355 (-0.79%)

, BMY

Bristol-Myers

$57.84 /

+0.25 (+0.43%)

, EKTAY

Elekta

$11.49 /

-0.14 (-1.20%)

, GRTX

Galera Therapeutics

$1.84 /

+0.02 (+1.10%)

, DNA

Ginkgo Bioworks

$14.27 /

+1.145 (+8.72%)

, HTHIY

Hitachi

$119.48 /

+1.76 (+1.50%)

, MRK

Merck

$81.68 /

+0.52 (+0.64%)

, MYGN

Myriad Genetics

$32.47 /

+0.03 (+0.09%)

, NBTX

Nanobiotix

$12.35 /

-0.7 (-5.36%)

, NNOX

Nano-X Imaging

$23.08 /

+0.345 (+1.52%)

, NTRA

Natera

$115.78 /

+0.82 (+0.71%)

, NVCR

Novocure

$119.37 /

-1.5 (-1.24%)

, PHG

Philips

$47.81 /

-0.3 (-0.62%)

, REGN

Regeneron

$576.15 /

+3.42 (+0.60%)

, SNY

Sanofi

$49.85 /

+ (+0.00%)

, SGEN

Seagen

$175.45 /

+4.14 (+2.42%)

, SMMNY

Siemens Healthineers

$34.73 /

+0.342 (+0.99%)

, SYK

Stryker

$273.17 /

-2.71 (-0.98%)

, TDY

Teledyne

$444.97 /

-1.14 (-0.26%)

, VRAY

ViewRay

$7.01 /

+0.205 (+3.01%)

, VREX

Varex Imaging

$27.05 /

+0.12 (+0.45%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

EKTAY Elekta
$11.49 /

-0.14 (-1.20%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$83.37 /

-1.515 (-1.78%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
10/08/21 Morgan Stanley
Bristol-Myers' UC trial miss an incremental negative, says Morgan Stanley
EKTAY Elekta
$11.49 /

-0.14 (-1.20%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$81.68 /

+0.52 (+0.64%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$115.78 /

+0.82 (+0.71%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$119.37 /

-1.5 (-1.24%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$47.81 /

-0.3 (-0.62%)

10/25/21 Credit Suisse
Philips price target lowered to EUR 42 from EUR 49 at Credit Suisse
10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
REGN Regeneron
$576.15 /

+3.42 (+0.60%)

10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
SNY Sanofi
$49.85 /

+ (+0.00%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
SGEN Seagen
$175.45 /

+4.14 (+2.42%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$273.17 /

-2.71 (-0.98%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$444.97 /

-1.14 (-0.26%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

VRAY ViewRay
$7.01 /

+0.205 (+3.01%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

NBTX Nanobiotix
$12.35 /

-0.7 (-5.36%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BIOC Biocept
$3.84 /

-0.02 (-0.52%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

ARAY Accuray
$4.39 /

+0.02 (+0.46%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.85 /

+ (+0.00%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

HTHIY Hitachi
$119.48 /

+1.76 (+1.50%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

VREX Varex Imaging
$27.05 /

+0.12 (+0.45%)

SYK Stryker
$273.17 /

-2.71 (-0.98%)

SNY Sanofi
$49.85 /

+ (+0.00%)

SMMNY Siemens Healthineers
$34.73 /

+0.342 (+0.99%)

SGEN Seagen
$175.45 /

+4.14 (+2.42%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

PHG Philips
$47.81 /

-0.3 (-0.62%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NVCR Novocure
$119.37 /

-1.5 (-1.24%)

NTRA Natera
$115.78 /

+0.82 (+0.71%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

MYGN Myriad Genetics
$32.47 /

+0.03 (+0.09%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

BAYRY Bayer
$14.16 /

+0.025 (+0.18%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

TDY Teledyne
$444.97 /

-1.14 (-0.26%)

REGN Regeneron
$576.15 /

+3.42 (+0.60%)

NVS Novartis
$83.37 /

-1.515 (-1.78%)

NNOX Nano-X Imaging
$23.08 /

+0.345 (+1.52%)

MRK Merck
$81.68 /

+0.52 (+0.64%)

GRTX Galera Therapeutics
$1.84 /

+0.02 (+1.10%)

DNA Ginkgo Bioworks
$14.27 /

+1.145 (+8.72%)

BSX Boston Scientific
$44.49 /

-0.355 (-0.79%)

BMY Bristol-Myers
$57.84 /

+0.25 (+0.43%)

AZN AstraZeneca
$61.75 /

-0.06 (-0.10%)

Conference/Events
American Society for Radiation Oncology to hold annual meeting » 08:46
10/25/21
10/25
08:46
10/25/21
08:46
ARAY

Accuray

$4.37 /

+0.3 (+7.37%)

, NVS

Novartis

$84.88 /

+0.2 (+0.24%)

, AZN

AstraZeneca

$61.81 /

+0.62 (+1.01%)

, BAYRY

Bayer

$14.13 /

+0.04 (+0.28%)

, BD

Budget Group

/

+

, BIOC

Biocept

$3.85 /

-0.09 (-2.28%)

, BSX

Boston Scientific

$44.85 /

-0.045 (-0.10%)

, BMY

Bristol-Myers

$57.59 /

-0.225 (-0.39%)

, EKTAY

Elekta

$11.63 /

+0.29 (+2.56%)

, GRTX

Galera Therapeutics

$1.83 /

-0.185 (-9.20%)

, DNA

Ginkgo Bioworks

$13.13 /

-0.08 (-0.61%)

, HTHIY

Hitachi

$117.72 /

+0.79 (+0.68%)

, MRK

Merck

$81.16 /

-0.01 (-0.01%)

, MYGN

Myriad Genetics

$32.49 /

-0.005 (-0.02%)

, NBTX

Nanobiotix

$13.05 /

+ (+0.00%)

, NNOX

Nano-X Imaging

$22.72 /

-1.01 (-4.26%)

, NTRA

Natera

$114.98 /

+2.56 (+2.28%)

, NVCR

Novocure

$120.88 /

-1.28 (-1.05%)

, PHG

Philips

$48.11 /

+0.6 (+1.26%)

, REGN

Regeneron

$572.62 /

+3.73 (+0.66%)

, SNY

Sanofi

$49.87 /

+0.67 (+1.36%)

, SGEN

Seagen

$171.55 /

-2.33 (-1.34%)

, SMMNY

Siemens Healthineers

$34.39 /

+0.238 (+0.70%)

, SYK

Stryker

$275.78 /

-0.69 (-0.25%)

, TDY

Teledyne

$446.11 /

+2.415 (+0.54%)

, VRAY

ViewRay

$6.81 /

+0.075 (+1.11%)

, VREX

Varex Imaging

$26.93 /

+0.15 (+0.56%)

63rd Annual ASTRO Meeting…

63rd Annual ASTRO Meeting 2021 will be held in Chicago on October 24-27.Webcast Link

ShowHide Related Items >><<
VRAY ViewRay
$6.81 /

+0.075 (+1.11%)

TDY Teledyne
$446.11 /

+2.415 (+0.54%)

SYK Stryker
$275.78 /

-0.69 (-0.25%)

SNY Sanofi
$49.87 /

+0.67 (+1.36%)

SMMNY Siemens Healthineers
$34.39 /

+0.238 (+0.70%)

SGEN Seagen
$171.55 /

-2.33 (-1.34%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NVCR Novocure
$120.88 /

-1.28 (-1.05%)

NTRA Natera
$114.98 /

+2.56 (+2.28%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

NBTX Nanobiotix
$13.05 /

+ (+0.00%)

MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

HTHIY Hitachi
$117.72 /

+0.79 (+0.68%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

EKTAY Elekta
$11.63 /

+0.29 (+2.56%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BIOC Biocept
$3.85 /

-0.09 (-2.28%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
NVS Novartis
$84.88 /

+0.2 (+0.24%)

10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
09/20/21 Deutsche Bank
Novartis downgraded to Sell from Hold at Deutsche Bank
AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

10/21/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
08/09/21 Berenberg
Bayer price target lowered to EUR 60 from EUR 74 at Berenberg
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
08/06/21 Credit Suisse
Bayer price target lowered to EUR 55 from EUR 60 at Credit Suisse
BD Budget Group
/

+

BIOC Biocept
$3.85 /

-0.09 (-2.28%)

10/08/21 Brookline
Biocept assumed with a Buy at Brookline
BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

10/06/21 Piper Sandler
Boston Scientific acquisition of Baylis looks 'solid,' says Piper Sandler
09/22/21 Piper Sandler
Boston Scientific said unlikely to hit low end of Q3 sales outlook, notes Piper
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
10/08/21 Morgan Stanley
Bristol-Myers' UC trial miss an incremental negative, says Morgan Stanley
10/08/21 Barclays
Bristol-Myers price target lowered to $68 from $71 at Barclays
EKTAY Elekta
$11.63 /

+0.29 (+2.56%)

08/27/21 JPMorgan
Elekta price target raised to SEK 95 from SEK 91 at JPMorgan
06/02/21 JPMorgan
Elekta price target raised to SEK 91 from SEK 82 at JPMorgan
04/27/21 JPMorgan
Elekta price target raised to SEK 82 from SEK 80 at JPMorgan
03/18/21 JPMorgan
Elekta downgraded to Underweight from Neutral at JPMorgan
GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

10/21/21 Citi
Galera Therapeutics price target lowered to $11 from $21 at Citi
10/20/21 H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
10/13/21 Raymond James
Ginkgo Bioworks initiated with an Outperform at Raymond James
10/12/21 William Blair
Blair starts Ginkgo at Outperform on 'significant' competitive advantage
10/12/21 William Blair
Ginkgo Bioworks initiated with an Outperform at William Blair
HTHIY Hitachi
$117.72 /

+0.79 (+0.68%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
MRK Merck
$81.16 /

-0.01 (-0.01%)

10/22/21 SVB Leerink
Merck price target raised to $105 from $104 at SVB Leerink
10/19/21 Roth Capital
Enanta drug 'naturally more potent' than Merck's antiviral, says Roth Capital
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NBTX Nanobiotix
$13.05 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
NTRA Natera
$114.98 /

+2.56 (+2.28%)

10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
NVCR Novocure
$120.88 /

-1.28 (-1.05%)

10/25/21 Piper Sandler
Novocure price target lowered to $195 from $235 at Piper Sandler
09/21/21 Piper Sandler
Novocure clinical update should come in next few weeks, says Piper Sandler
07/30/21 Mizuho
Novocure price target lowered to $200 from $229 at Mizuho
PHG Philips
$48.11 /

+0.6 (+1.26%)

10/19/21 JPMorgan
Philips price target lowered to EUR 36.40 from EUR 40.90 at JPMorgan
10/19/21 Deutsche Bank
Philips price target lowered to EUR 42 from EUR 43 at Deutsche Bank
09/10/21 Barclays
Philips price target lowered to EUR 53 from EUR 54 at Barclays
09/08/21
Fly Intel: Top five analyst initiations
REGN Regeneron
$572.62 /

+3.73 (+0.66%)

10/22/21 H.C. Wainwright
Regeneron price target raised to $842 from $831 at H.C. Wainwright
10/14/21 H.C. Wainwright
H.C. Wainwright 'enthusiastic' on Regeneron, sees no barrier for REGEN-COV nod
10/04/21 Piper Sandler
Amgen's AMG 451 looks competitive with Dupixent, says Piper Sandler
10/04/21 H.C. Wainwright
Regeneron selloff brings 'excellent entry point,' says H.C. Wainwright
SNY Sanofi
$49.87 /

+0.67 (+1.36%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
SGEN Seagen
$171.55 /

-2.33 (-1.34%)

10/14/21 BTIG
Seagen assumed with a Neutral at BTIG
09/27/21 RBC Capital
Seagen price target raised to $154 from $148 at RBC Capital
05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
SMMNY Siemens Healthineers
$34.39 /

+0.238 (+0.70%)

10/13/21 UBS
Siemens Healthineers price target raised to EUR 54 from EUR 48 at UBS
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold at Societe Generale
10/01/21 Societe Generale
Siemens Healthineers downgraded to Hold from Buy at Societe Generale
09/10/21 Barclays
Siemens Healthineers price target raised to EUR 55 from EUR 49 at Barclays
SYK Stryker
$275.78 /

-0.69 (-0.25%)

09/14/21 Raymond James
Stryker resumed with a Market Perform at Raymond James
07/29/21 Argus
Stryker price target raised to $320 from $280 at Argus
07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 SVB Leerink
Stryker price target raised to $300 from $290 at SVB Leerink
TDY Teledyne
$446.11 /

+2.415 (+0.54%)

07/30/21 Cowen
Teledyne price target raised to $525 from $500 at Cowen
06/08/21 Goldman Sachs
Teledyne reinstated with a Neutral at Goldman Sachs
05/25/21 BofA
Teledyne initiated with a Buy at BofA
04/29/21 Needham
Teledyne price target raised to $500 from $416 at Needham
VRAY ViewRay
$6.81 /

+0.075 (+1.11%)

10/19/21 Piper Sandler
ViewRay strength attributed to MIRAGE study recruiting halt, says Piper Sandler
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
10/14/21 B. Riley
ViewRay resumed with a Neutral at B. Riley
06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
VREX Varex Imaging
$26.93 /

+0.15 (+0.56%)

02/05/21 Oppenheimer
Varex Imaging upgraded to Outperform from Perform at Oppenheimer
VREX Varex Imaging
$26.93 /

+0.15 (+0.56%)

VRAY ViewRay
$6.81 /

+0.075 (+1.11%)

TDY Teledyne
$446.11 /

+2.415 (+0.54%)

SYK Stryker
$275.78 /

-0.69 (-0.25%)

SNY Sanofi
$49.87 /

+0.67 (+1.36%)

SGEN Seagen
$171.55 /

-2.33 (-1.34%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NVCR Novocure
$120.88 /

-1.28 (-1.05%)

NTRA Natera
$114.98 /

+2.56 (+2.28%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

NBTX Nanobiotix
$13.05 /

+ (+0.00%)

MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BIOC Biocept
$3.85 /

-0.09 (-2.28%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

ARAY Accuray
$4.37 /

+0.3 (+7.37%)

  • 22
    Jul
  • 11
    Feb
  • 22
    Jan
  • 05
    Jan
  • 11
    Dec
SNY Sanofi
$49.87 /

+0.67 (+1.36%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

HTHIY Hitachi
$117.72 /

+0.79 (+0.68%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

VREX Varex Imaging
$26.93 /

+0.15 (+0.56%)

SYK Stryker
$275.78 /

-0.69 (-0.25%)

SNY Sanofi
$49.87 /

+0.67 (+1.36%)

SMMNY Siemens Healthineers
$34.39 /

+0.238 (+0.70%)

SGEN Seagen
$171.55 /

-2.33 (-1.34%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

PHG Philips
$48.11 /

+0.6 (+1.26%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NVCR Novocure
$120.88 /

-1.28 (-1.05%)

NTRA Natera
$114.98 /

+2.56 (+2.28%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

MYGN Myriad Genetics
$32.49 /

-0.005 (-0.02%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

BAYRY Bayer
$14.13 /

+0.04 (+0.28%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

TDY Teledyne
$446.11 /

+2.415 (+0.54%)

REGN Regeneron
$572.62 /

+3.73 (+0.66%)

NVS Novartis
$84.88 /

+0.2 (+0.24%)

NNOX Nano-X Imaging
$22.72 /

-1.01 (-4.26%)

MRK Merck
$81.16 /

-0.01 (-0.01%)

GRTX Galera Therapeutics
$1.83 /

-0.185 (-9.20%)

DNA Ginkgo Bioworks
$13.13 /

-0.08 (-0.61%)

BSX Boston Scientific
$44.85 /

-0.045 (-0.10%)

BMY Bristol-Myers
$57.59 /

-0.225 (-0.39%)

AZN AstraZeneca
$61.81 /

+0.62 (+1.01%)

Hot Stocks
Cameco, GE Hitachi, GEH SMR, SGE collaborate on deployment of BWRX-300 SMRs » 07:22
09/23/21
09/23
07:22
09/23/21
07:22
CCJ

Cameco

$21.01 /

-0.06 (-0.28%)

, GE

General Electric

$98.55 /

+1.68 (+1.73%)

, HTHIY

Hitachi

$116.78 /

-1.612 (-1.36%)

Cameco (CCJ), GE Hitachi…

Cameco (CCJ), GE Hitachi Nuclear Energy (GE, HTHIY), GEH SMR Technologies Canada and Synthos Green Energy have entered into a Memorandum of Understanding to evaluate the potential establishment of a uranium fuel supply chain in Canada capable of servicing a potential fleet of BWRX-300 small modular reactors in Poland. Synthos, a manufacturer of synthetic rubber and one of the biggest producers of chemical raw materials in Poland, is interested in obtaining affordable, on-demand, carbon-free electricity from a dependable, dedicated source. In 2019 SGE and GEH agreed to collaborate on potential deployment applications for the BWRX-300 in Poland. SGE and GEH signed a strategic agreement in 2020 that further advanced the cooperation. Cameco supplies uranium, uranium refining and conversion services to the nuclear industry worldwide. In July 2021, Cameco, GEH and Global Nuclear Fuel-Americas agreed to explore several areas of cooperation to advance the commercialization and deployment of BWRX-300 SMRs in Canada and around the world. The BWRX-300 is a 300 MWe water-cooled, natural circulation SMR with passive safety systems that leverages the design and licensing basis of GEH's U.S. NRC-certified ESBWR. Through dramatic and innovative design simplification, GEH projects the BWRX-300 will require significantly less capital cost per MW when compared to other SMR designs. By leveraging the existing ESBWR design certification, utilizing the licensed and proven GNF2 fuel design, and incorporating proven components and supply chain expertise, GEH believes the BWRX-300 can become the lowest-risk, most cost-competitive and quickest to market SMR. This MOU is non-exclusive and non-binding.

ShowHide Related Items >><<
HTHIY Hitachi
$116.78 /

-1.612 (-1.36%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

CCJ Cameco
$21.01 /

-0.06 (-0.28%)

CCJ Cameco
$21.01 /

-0.06 (-0.28%)

09/17/21 Raymond James
Cameco price target raised to C$34 from C$29 at Raymond James
09/15/21 TD Securities
Cameco price target raised to C$35 from C$25 at TD Securities
09/07/21 Raymond James
Cameco price target raised to C$29 from C$25 at Raymond James
09/02/21 RBC Capital
Cameco upgraded to Sector Perform from Underperform at RBC Capital
GE General Electric
$98.55 /

+1.68 (+1.73%)

09/03/21 JPMorgan
Los Angeles vote shows 'secular decline' risk of GE Power, says JPMorgan
08/11/21 Citi
GE price target adjusted to $136 at Citi to account for reverse split
08/11/21 JPMorgan
GE industrial FCF a 'construct' that is 'detached from reality,' says JPMorgan
07/14/21 Deutsche Bank
General Electric price target lowered to $14 from $15 at Deutsche Bank
HTHIY Hitachi
$116.78 /

-1.612 (-1.36%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
10/15/20 Jefferies
Hitachi initiated with a Buy at Jefferies
GE General Electric
$98.55 /

+1.68 (+1.73%)

CCJ Cameco
$21.01 /

-0.06 (-0.28%)

HTHIY Hitachi
$116.78 /

-1.612 (-1.36%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

GE General Electric
$98.55 /

+1.68 (+1.73%)

CCJ Cameco
$21.01 /

-0.06 (-0.28%)

Over a quarter ago
Periodicals
Thales in talks to sell signaling unit to Hitachi for EUR1.7B, Reuters says » 14:18
08/03/21
08/03
14:18
08/03/21
14:18
THLLY

Thales

$21.06 /

+0.11 (+0.53%)

, HTHIY

Hitachi

$111.66 /

-0.32 (-0.29%)

Thales (THLLY) is in…

Thales (THLLY) is in advanced talks to sell its railway signaling unit to Hitachi (HTHIY) for roughly EUR1.7B, Reuters' Gwenaelle Barzic reports, citing a source familiar with the discussions. The deal is set to be announced within the coming days, the author says. Reference Link

ShowHide Related Items >><<
HTHIY Hitachi
$111.66 /

-0.32 (-0.29%)

THLLY Thales
$21.06 /

+0.11 (+0.53%)

07/27/21 Deutsche Bank
Thales price target raised to EUR 108 from EUR 100 at Deutsche Bank
07/26/21 Societe Generale
Thales price target lowered to EUR 101 from EUR 105 at Societe Generale
07/26/21 JPMorgan
Thales price target raised to EUR 125 from EUR 105 at JPMorgan
07/26/21 Barclays
Thales price target raised to EUR 91 from EUR 88 at Barclays
HTHIY Hitachi
$111.66 /

-0.32 (-0.29%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
10/15/20 Jefferies
Hitachi initiated with a Buy at Jefferies
Hot Stocks
General Electric, Hitachi announce cross-licensing agreement for SF6 » 05:18
04/21/21
04/21
05:18
04/21/21
05:18
GE

General Electric

$13.06 /

-0.405 (-3.01%)

, HTHIY

Hitachi

$91.49 /

-3.23 (-3.41%)

General Electric…

General Electric Renewable Energy's Grid Solutions business (GE) and Hitachi ABB Power Grids (HTHIY) announced a non-exclusive, cross-licensing agreement related to the use of an alternative gas to sulfur hexafluoride, or SF6, used in high voltage equipment. This fluoronitrile-based gas mixture has a significantly reduced impact on the environment compared to SF6. Under this landmark agreement announced between the two companies, both companies will share complementary intellectual property related to their respective SF6-free solutions. This will help accelerate the use of fluoronitrile-based eco-efficient insulation and switching gas in high-voltage equipment as an alternative to SF6. A recent EU Commission report concluded that fluorinitrile-based gas mixtures may be the only insulating and switching gas alternative to SF6 when space is a constraint. The companies said, "Today's historic agreement paves the way for a standard SF6-free solution for high-voltage equipment in the coming years. This would enable utilities and industries to accelerate their reduction of greenhouse gas emissions, while facilitating their ability to plan, as well as operate and maintain their networks thanks to standardized services and the use of the same auxiliary equipment. For almost half a century, SF6 gas has been the norm in the electrical power transmission and distribution industry due to its unique physical properties. It is, however a greenhouse gas that contributes to global warming if leaked. For this reason, GE and Hitachi ABB Power Grids have been investing in the development of better alternatives to SF6."

ShowHide Related Items >><<
GE General Electric
$13.06 /

-0.405 (-3.01%)

GE General Electric
$13.06 /

-0.405 (-3.01%)

04/09/21 UBS
General Electric price target raised to $17 from $15 at UBS
03/18/21 JPMorgan
GE consensus estimates overestimate cash flow, says JPMorgan
03/15/21 UBS
General Electric's cash outlook 'conservative', says UBS
03/15/21 Morgan Stanley
Boeing price target raised to $274 from $250 at Morgan Stanley
HTHIY Hitachi
$91.49 /

-3.23 (-3.41%)

11/20/20 Goldman Sachs
Hitachi reinstated with a Sell at Goldman Sachs
10/15/20 Jefferies
Hitachi initiated with a Buy at Jefferies
07/20/20 SMBC Nikko
Hitachi downgraded to Neutral from Outperform at SMBC Nikko
04/22/20 UBS
Hitachi downgraded to Neutral from Buy at UBS
GE General Electric
$13.06 /

-0.405 (-3.01%)

HTHIY Hitachi
$91.49 /

-3.23 (-3.41%)

GE General Electric
$13.06 /

-0.405 (-3.01%)

GE General Electric
$13.06 /

-0.405 (-3.01%)

GE General Electric
$13.06 /

-0.405 (-3.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.